Meta-analysis of observational studies suggests better long-term oncologic outcomes with propofol-based total intravenous anesthesia compared to any volatile anesthesia
14 Mar, 2021 | 19:59h | UTC
Commentary on Twitter
? Patients who receive propofol-based TIVA for cancer surgery are associated with better overall survival than volatile anesthesia though there is no statistically significant difference in cancer-free survival between propofol-based TIVA https://t.co/lJHxmcqjtB pic.twitter.com/7gYmZYZRij
— Anesthesia&Analgesia (@IARS_Journals) March 3, 2021